These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10727306)

  • 21. Management of allergy to heparins in postoperative care: subcutaneous allergy and intravenous tolerance.
    Seitz CS; Brocker EB; Trautmann A
    Dermatol Online J; 2008 Sep; 14(9):4. PubMed ID: 19061586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The complex clinical picture of side effects to anticoagulation.
    Trautmann A; Seitz CS
    Med Clin North Am; 2010 Jul; 94(4):821-34, xii-iii. PubMed ID: 20609865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed-type hypersensitivity to subcutaneous enoxaparin.
    Méndez J; Sanchís ME; de la Fuente R; Stolle R; Vega JM; Martínez C; Armentia A; Sánchez P; Fernández A
    Allergy; 1998 Oct; 53(10):999-1003. PubMed ID: 9821483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Hirsh J; Bauer KA; Donati MB; Gould M; Samama MM; Weitz JI
    Chest; 2008 Jun; 133(6 Suppl):141S-159S. PubMed ID: 18574264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed hypersensitivity to one low-molecular-weight heparin with tolerance of other low-molecular-weight heparins.
    Bircher AJ; Itin PH; Tsakiris DA; Surber C
    Br J Dermatol; 1995 Mar; 132(3):461-3. PubMed ID: 7718467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-immediate heparin and heparinoid cutaneous allergic reactions: a role for fondaparinux.
    Tan E; Thompson G; Ekstrom C; Lucas M
    Intern Med J; 2018 Jan; 48(1):73-77. PubMed ID: 29314514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed allergic skin reactions to subcutaneous heparins. Tolerance of 2 recombinant hirudins.
    Koch P; Reinhold S; Busch C
    Contact Dermatitis; 2000 May; 42(5):278-9. PubMed ID: 10789845
    [No Abstract]   [Full Text] [Related]  

  • 29. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction.
    Bircher AJ; Flückiger R; Buchner SA
    Br J Dermatol; 1990 Oct; 123(4):507-14. PubMed ID: 2151304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed-type skin reaction to the heparin-alternative danaparoid.
    Szolar-Platzer C; Aberer W; Kränke B
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):920-2. PubMed ID: 11044823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulant-related skin reactions.
    Jörg I; Fenyvesi T; Harenberg J
    Expert Opin Drug Saf; 2002 Sep; 1(3):287-94. PubMed ID: 12904144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Delayed-type allergy for heparin and fractions of low-molecular-weight heparin].
    de Kort WJ; van der Meer YG; de Groot AC
    Ned Tijdschr Geneeskd; 1992 Nov; 136(48):2379-80. PubMed ID: 1334235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins.
    Lopez S; Torres MJ; Rodríguez-Pena R; Blanca-Lopez N; Fernandez TD; Antunez C; Canto G; de Luque V; Mayorga C
    Br J Dermatol; 2009 Feb; 160(2):259-65. PubMed ID: 18945304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Heparin-induced thrombocytopenia type II. Intra- and postoperative lepirudin treatment in acute ischemia of the extremities].
    Schmidt O; Lang W
    Dtsch Med Wochenschr; 1998 Oct; 123(41):1207-10. PubMed ID: 9810286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed-type heparin allergy: diagnostic procedures and treatment alternatives-a case series including 15 patients.
    Pföhler C; Müller CS; Pindur G; Eichler H; Schäfers HJ; Grundmann U; Tilgen W
    World Allergy Organ J; 2008 Dec; 1(12):194-9. PubMed ID: 23282847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type IV hypersensitivity to subcutaneous heparin: a new case.
    Gonzalo Garijo MA; Revenga Arranz F
    J Investig Allergol Clin Immunol; 1996; 6(6):388-91. PubMed ID: 9015784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility of subcutaneous hirudins.
    Deitcher SR
    Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S27-31. PubMed ID: 14593980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low molecular weight heparin-induced skin necrosis-a systematic review.
    Handschin AE; Trentz O; Kock HJ; Wanner GA
    Langenbecks Arch Surg; 2005 Jun; 390(3):249-54. PubMed ID: 15570433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
    Sandercock PA; Counsell C; Tseng MC
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000119. PubMed ID: 18646059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial.
    Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P
    J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.